News and Events

Hatchtech completes treatment phase of 2b clinical trial of new-generation headlice treatment DeOvo™

31/08/2011 | Press Releases

Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2 clinical study to confirm the efficacy of its novel head lice treatment DeOvo™.

Download PDF


Categories